Evidence map›Paper›PMID 31945029›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2020

Anti-Inflammatory and Antioxidant Effects of Acetyl-L-Carnitine on Atherosclerotic Rats.

Shixun Wang, Jingtao Xu, Jiahui Zheng, Xincai Zhang, Jingbo Shao, Luyan Zhao, Junqiang Hao

Open access · bronzeAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Mitochondria as a Therapeutic Target in Metabolic Disorders.Mini reviews in medicinal chemistry · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Acetyl-L-Carnitine and Liposomal Co-Enzyme QInternational journal of molecular sciences · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shixun WangSecond Department of Cardiology, Weifang People's Hospital, Weifang, Shandong, China (mainland).
Jingtao XuSecond Department of Cardiology, Weifang People's Hospital, Weifang, Shandong, China (mainland).
Jiahui ZhengSecond Department of Cardiology, Weifang People's Hospital, Weifang, Shandong, China (mainland).
Xincai ZhangSecond Department of Cardiology, Weifang People's Hospital, Weifang, Shandong, China (mainland).
Jingbo ShaoSecond Department of Cardiology, Weifang People's Hospital, Weifang, Shandong, China (mainland).
Luyan ZhaoDepartment of Emergency Medicine, Weifang Brain Hospital, Weifang, Shandong, China (mainland).
Junqiang HaoDepartment of Emergency Medicine, Weifang Brain Hospital, Weifang, Shandong, China (mainland).
Weifang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND The purpose of the present study was to evaluate the regulatory effects of acetyl-L-carnitine (ALCAR) on atherosclerosis in Wister rats and to explore its anti-atherosclerotic mechanism. MATERIAL AND METHODS We randomly divided 32 Wister rats into 4 groups: a normal diet group (control group, n=8), a normal diet+ALCAR group (ALCAR group, n=8), an atherosclerosis group (AS group, n=8), and an atherosclerosis+ALCAR group (AS+ALCAR group, n=8). The serum lipid distribution, oxidative stress, inflammatory factors and adiponectin (APN) in the blood, and heart and aortic tissues were determined using the standard assay kits, xanthine oxidase method, and ELISA, respectively. HE staining was performed to observe aortic pathology structure change, and the level of angiotensin II (AngII) in the aorta was assessed using radioimmunoassay. In addition, real-time quantitative PCR and Western blot analysis were applied to detect the expression of iNOS, IL-1ß, TNF-alpha, and CRP in the aortic and heart tissues. RESULTS Compared with the AS group, the levels of serum TC, TG, LDL, and VLDL in rats decreased significantly, while HDL level significantly increased in the AS+ALCAR group. ALCAR administration enhanced the SOD and GSH-Px activities and decreased MDA activity. APN level was significantly elevated in the AS group, but ALCAR had no significant effect on APN. Further, ALCAR reduced the expressions of inflammation factors TNF-alpha, IL-1ß, iNOS, and CRP, and the concentration of AngII in serum, aortic, and heart tissues. CONCLUSIONS ALCAR can inhibit the expressions of inflammatory factors and antioxidation to suppress the development of atherosclerosis by adjusting blood lipid in the myocardium of AS rats.

Indexed as

AcetylcarnitineAdiponectinAngiotensin IIAnimalsAnti-Inflammatory AgentsAntioxidantsAortaAtherosclerosisBiomarkersC-Reactive ProteinInflammation MediatorsInterleukin-1betaLipidsMaleMyocardiumNitric Oxide Synthase Type IIAcetylcarnitineAdiponectinAngiotensin IIAnti-Inflammatory AgentsAntioxidantsBiomarkersC-Reactive ProteinInflammation MediatorsInterleukin-1betaLipidsNitric Oxide Synthase Type IIReactive Oxygen SpeciesRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID31945029
PMCPMC6984015
OpenAlexW2999184754

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.